What Researchers Did
Researchers surveyed acute care hospitals in Washington, Idaho, Montana, and Alaska to assess their ability to measure blood carboxyhemoglobin (COHb) levels, which are essential for diagnosing carbon monoxide poisoning.
What They Found
Only 44% of acute care hospitals in the surveyed region had the capability to measure COHb levels. Hospitals with co-oximetry obtained results in an average of 10 minutes, while those without took an average of 904 minutes (about 15 hours). Over 90% of carbon monoxide-poisoned patients referred for hyperbaric treatment came from hospitals that could measure COHb.
What This Means for Canadian Patients
This study highlights the critical importance of rapid carboxyhemoglobin measurement for the timely diagnosis of carbon monoxide poisoning. Delays in obtaining these results could significantly impact the speed at which Canadian patients receive a diagnosis and access potentially life-saving treatments like hyperbaric oxygen therapy.
Canadian Relevance
This study covers carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy. No direct Canadian connection identified.
Study Limitations
This study was conducted in a specific region of the United States, so its findings may not directly reflect the situation in the Canadian healthcare system.